Author Index: K
• FIRST USER EXPERIENCES FROM A MULTI-CENTER IMPLEMENTATION OF A WEB-BASED PROSTATE CANCER TREATMENT DECISION AID IN THE NETHERLANDS
• PREFERENCE FOR DECISION MAKING ROLE IN PROSTATE CANCER SURVIVORS IS ASSOCIATED WITH ILLNESS PERCEPTIONS AND SATISFACTION WITH INFORMATION PROVISION: RESULTS FROM THE PROFILES-REGISTRY
• PREFERENCE FOR DECISION MAKING ROLE IN PROSTATE CANCER SURVIVORS IS ASSOCIATED WITH ILLNESS PERCEPTIONS AND SATISFACTION WITH INFORMATION PROVISION: RESULTS FROM THE PROFILES-REGISTRY
• PATIENT PERCEPTIONS ABOUT COLORECTAL CANCER SCREENING AFTER VIEWING A DECISION AID TARGETED TO OLDER ADULTS
• RANDOMIZED TRIAL OF A DECISION AID TO PROMOTE APPROPRIATE COLORECTAL CANCER SCREENING AMONG OLDER ADULTS
• INFLUENCES ON PRIMARY CARE PROVIDERS' RECOMMENDATIONS FOR HYPOTHETICAL PROSTATE AND COLON CANCER SCREENING IN OLDER ADULTS: A WITHIN-SUBJECTS EXPERIMENT
• RANDOMIZED TRIAL OF A DECISION AID TO PROMOTE APPROPRIATE COLORECTAL CANCER SCREENING AMONG OLDER ADULTS
• INFLUENCES ON PRIMARY CARE PROVIDERS' RECOMMENDATIONS FOR HYPOTHETICAL PROSTATE AND COLON CANCER SCREENING IN OLDER ADULTS: A WITHIN-SUBJECTS EXPERIMENT
• COST-EFFECTIVENESS OF TELEHOMECARE FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN CANADA
• PREDICTING UTILITY SCORES FOR MYELOFIBROSIS PATIENTS: MAPPING THE MYELOFIBROSIS SYMPTOM ASSESSMENT FORM AND MYELOPROLIFERATIVE SYMPTOM ASSESSMENT FORM TO THE EUROQOL-5D
• CURRENT TREATMENT FOR CHRONIC HEPATITIS B (CHB): A SYSTEMATIC REVIEW AND A NETWORK META-ANALYSIS
• BURDEN OF COMMUNITY-ACQUIRED CLOSTRIDIUM DIFFICILE INFECTION IN ONTARIO, CANADA: A POPULATION-BASED STUDY
• A COST-EFFECTIVENESS ANALYSIS OF MINIMAL RESIDUAL DISEASE TESTING FOR THE MANAGEMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
• ONE YEAR HEALTHCARE COST AND UTILIZATION IN ADULTS WITH CHRONIC PAIN
• ESTIMATION OF FIBROSIS PROGRESSION RATES FOR CHRONIC HEPATITIS C: A SYSTEMATIC REVIEW AND META-ANALYSIS UPDATE
• IMPLEMENTATION AND ADOPTION OF THE TELEHOMECARE PROGRAM FOR PATIENTS WITH HEART FAILURE OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
• HEALTH UTILITIES IN MARGINALIZED CHRONIC HEPATITIS C PATIENTS PARTICIPATING IN A COMMUNITY-BASED HEPATITIS C PROGRAM
• IMPACT OF TELEHOMECARE PROGRAM ON MONITORING PARAMETERS AMONG COPD AND HF PATIENTS
• IMPACT OF TELEHOMECARE PROGRAM ON PATIENTS' QUALITY OF LIFE AND DISEASE-MANAGEMENT SKILLS
• NEW MODEL OF HEALTHCARE DELIVERY-TELEHOMECARE PROGRAM FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND HEART FAILURE (HF) PATIENTS IN ONTARIO, CANADA
• FACTORS AFFECTING THE DELIVERY OF A PHARMACIST-LED MEDICATION REVIEW. EVIDENCE FROM THE MEDSCHECK ANNUAL SERVICE IN ONTARIO
• SOCIAL MEDIA AS A KEY TOOL TO RECRUIT RARE DISEASE PATIENTS FOR CLINICAL RESEARCHERS
• COST-UTILITY ANALYSIS OF ORAL ANTISEPTIC CHLORHEXIDINE IN DECREASING VENTILATOR-ASSOCIATED PNEUMONIA IN INTENSIVE CARE UNITS
• MANAGEMENT OF EPILEPSY IN WOMEN CONTEMPLATING PREGNANCY: A DECISION ANALYSIS MODEL
• HEALTH UTILITIES IN ADULTS WITH CHRONIC PAIN
• PREDICTING UTILITY SCORES FOR MYELOFIBROSIS PATIENTS: MAPPING THE MYELOFIBROSIS SYMPTOM ASSESSMENT FORM AND MYELOPROLIFERATIVE SYMPTOM ASSESSMENT FORM TO THE EUROQOL-5D
• CURRENT TREATMENT FOR CHRONIC HEPATITIS B (CHB): A SYSTEMATIC REVIEW AND A NETWORK META-ANALYSIS
• BURDEN OF COMMUNITY-ACQUIRED CLOSTRIDIUM DIFFICILE INFECTION IN ONTARIO, CANADA: A POPULATION-BASED STUDY
• A COST-EFFECTIVENESS ANALYSIS OF MINIMAL RESIDUAL DISEASE TESTING FOR THE MANAGEMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
• ONE YEAR HEALTHCARE COST AND UTILIZATION IN ADULTS WITH CHRONIC PAIN
• ESTIMATION OF FIBROSIS PROGRESSION RATES FOR CHRONIC HEPATITIS C: A SYSTEMATIC REVIEW AND META-ANALYSIS UPDATE
• IMPLEMENTATION AND ADOPTION OF THE TELEHOMECARE PROGRAM FOR PATIENTS WITH HEART FAILURE OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
• HEALTH UTILITIES IN MARGINALIZED CHRONIC HEPATITIS C PATIENTS PARTICIPATING IN A COMMUNITY-BASED HEPATITIS C PROGRAM
• IMPACT OF TELEHOMECARE PROGRAM ON MONITORING PARAMETERS AMONG COPD AND HF PATIENTS
• IMPACT OF TELEHOMECARE PROGRAM ON PATIENTS' QUALITY OF LIFE AND DISEASE-MANAGEMENT SKILLS
• NEW MODEL OF HEALTHCARE DELIVERY-TELEHOMECARE PROGRAM FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND HEART FAILURE (HF) PATIENTS IN ONTARIO, CANADA
• FACTORS AFFECTING THE DELIVERY OF A PHARMACIST-LED MEDICATION REVIEW. EVIDENCE FROM THE MEDSCHECK ANNUAL SERVICE IN ONTARIO
• SOCIAL MEDIA AS A KEY TOOL TO RECRUIT RARE DISEASE PATIENTS FOR CLINICAL RESEARCHERS
• COST-UTILITY ANALYSIS OF ORAL ANTISEPTIC CHLORHEXIDINE IN DECREASING VENTILATOR-ASSOCIATED PNEUMONIA IN INTENSIVE CARE UNITS
• MANAGEMENT OF EPILEPSY IN WOMEN CONTEMPLATING PREGNANCY: A DECISION ANALYSIS MODEL
• HEALTH UTILITIES IN ADULTS WITH CHRONIC PAIN
• MODELING THE COST-EFFECTIVENESS OF OPIOID AGONIST TREATMENT POLICY ALTERNATIVES IN CALIFORNIA'S PUBLICLY-FUNDED DRUG TREATMENT FACILITIES
• INFORMING RESOURCE ALLOCATION DECISIONS IN HIV/AIDS: A CASE STUDY FOR BRITISH COLUMBIA, CANADA
• PROBABILISTIC MODEL-BASED PATTERN ANALYSIS OF HEALTH RESOURCE USE AMONG PEOPLE LIVING WITH HIV/AIDS
• INFORMING RESOURCE ALLOCATION DECISIONS IN HIV/AIDS: A CASE STUDY FOR BRITISH COLUMBIA, CANADA
• PROBABILISTIC MODEL-BASED PATTERN ANALYSIS OF HEALTH RESOURCE USE AMONG PEOPLE LIVING WITH HIV/AIDS
• VALUE OF INFORMATION ANALYSIS TO EXPLORE THE UNCERTAINTY OF AN EARLY IDENTIFICATION MODEL OF ALZHEIMER'S DISEASE
• VALUE OF INFORMATION ANALYSES OF GOUT THERAPIES: USING A META-MODELING APPROACH
• COST-EFFECTIVENESS OF WARFARIN AND DABIGATRAN TO PREVENT STROKE IN ELDERLY MALE PATIENTS WITH ATRIAL FIBRILLATION
• A NON-SAMPLING BASED METHOD FOR PROPAGATING PARAMETER UNCERTAINTY INTO STATE-TRANSITION MODELS
• THE PRIMACY OF PRIORS: THE EFFECT OF BAYESIAN PRIOR SELECTION ON THE ESTIMATED RISK OF INDUCED VZV DISSEMINATION FROM THE SHINGLES VACCINE IN IMMUNOCOMPROMISED PATIENTS
• INTRODUCING THE CURVE OF OPTIMAL SAMPLE SIZE (COSS): A GRAPHIC REPRESENTATION OF OPTIMAL SAMPLE SIZE BY WILLINGNESS-TO-PAY THRESHOLD
• PARTNER SERVICES PROGRAMS FOR CHLAMYDIAL INFECTION: A COMPARISON BETWEEN PARTNER NOTIFICATION AND EXPEDITED PARTNER THERAPY
• DOES SIZE MATTER? A METHOD FOR ADAPTIVELY DETERMINING CYCLE LENGTH IN A STATE-TRANSITION MODEL
• VALUE OF INFORMATION ANALYSES OF GOUT THERAPIES: USING A META-MODELING APPROACH
• COST-EFFECTIVENESS OF WARFARIN AND DABIGATRAN TO PREVENT STROKE IN ELDERLY MALE PATIENTS WITH ATRIAL FIBRILLATION
• A NON-SAMPLING BASED METHOD FOR PROPAGATING PARAMETER UNCERTAINTY INTO STATE-TRANSITION MODELS
• THE PRIMACY OF PRIORS: THE EFFECT OF BAYESIAN PRIOR SELECTION ON THE ESTIMATED RISK OF INDUCED VZV DISSEMINATION FROM THE SHINGLES VACCINE IN IMMUNOCOMPROMISED PATIENTS
• INTRODUCING THE CURVE OF OPTIMAL SAMPLE SIZE (COSS): A GRAPHIC REPRESENTATION OF OPTIMAL SAMPLE SIZE BY WILLINGNESS-TO-PAY THRESHOLD
• PARTNER SERVICES PROGRAMS FOR CHLAMYDIAL INFECTION: A COMPARISON BETWEEN PARTNER NOTIFICATION AND EXPEDITED PARTNER THERAPY
• DOES SIZE MATTER? A METHOD FOR ADAPTIVELY DETERMINING CYCLE LENGTH IN A STATE-TRANSITION MODEL